Álvarez-Torres, M.d.M.; Fuster-García, E.; Balaña, C.; Puig, J.; García-Gómez, J.M.
Lack of Benefit of Extending Temozolomide Treatment in Patients with High Vascular Glioblastoma with Methylated MGMT. Cancers 2021, 13, 5420.
https://doi.org/10.3390/cancers13215420
AMA Style
Álvarez-Torres MdM, Fuster-García E, Balaña C, Puig J, García-Gómez JM.
Lack of Benefit of Extending Temozolomide Treatment in Patients with High Vascular Glioblastoma with Methylated MGMT. Cancers. 2021; 13(21):5420.
https://doi.org/10.3390/cancers13215420
Chicago/Turabian Style
Álvarez-Torres, María del Mar, Elies Fuster-García, Carmen Balaña, Josep Puig, and Juan M. García-Gómez.
2021. "Lack of Benefit of Extending Temozolomide Treatment in Patients with High Vascular Glioblastoma with Methylated MGMT" Cancers 13, no. 21: 5420.
https://doi.org/10.3390/cancers13215420
APA Style
Álvarez-Torres, M. d. M., Fuster-García, E., Balaña, C., Puig, J., & García-Gómez, J. M.
(2021). Lack of Benefit of Extending Temozolomide Treatment in Patients with High Vascular Glioblastoma with Methylated MGMT. Cancers, 13(21), 5420.
https://doi.org/10.3390/cancers13215420